Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-015826
Filing Date
2004-03-15
Accepted
2004-03-15 15:49:18
Documents
2
Period of Report
2004-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4042
3 POA DOCUMENT poa.txt EX-24.4_35131 3889
  Complete submission text file 0001209191-04-015826.txt   9774
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 8320 GUILFORD RD STE C COLUMBIA MD 21046
Business Address
LYNCH FORD R (Reporting) CIK: 0001264766 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 04669509